A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumours

Alastair Greystoke, William P. Steward, Simon Pacey et al.|Annals of Oncology|2006

Cited by 24